Literature DB >> 6712872

Excretion of hydroxychloroquine in human milk.

R L Nation, L P Hackett, L J Dusci, K F Ilett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6712872      PMCID： PMC1463384          DOI： 10.1111/j.1365-2125.1984.tb02358.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  Excretion of drugs in human milk.

Authors:  T E O'Brien
Journal:  Am J Hosp Pharm       Date:  1974-09

Review 2.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

3.  Characterization of chloroquine plasma protein binding in man.

Authors:  O Walker; D J Birkett; G Alván; L L Gustafsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

4.  Breast-milk production in Australian women.

Authors:  S Rattigan; A V Ghisalberti; P E Hartmann
Journal:  Br J Nutr       Date:  1981-03       Impact factor: 3.718
  4 in total
  11 in total

1.  Drugs in lactation.

Authors:  D A MacKintosh
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

2.  Excretion of chloroquine, dapsone and pyrimethamine in human milk.

Authors:  M D Edstein; J R Veenendaal; K Newman; R Hyslop
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

3.  Excretion of chloroquine and desethylchloroquine in human milk.

Authors:  F A Ogunbona; C O Onyeji; O O Bolaji; S E Torimiro
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

Review 4.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

6.  Piroxicam in breast milk after long-term treatment.

Authors:  M Ostensen; I Matheson; H Laufen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.

Authors:  Julie Barsalou; Nathalie Costedoat-Chalumeau; Adey Berhanu; Cesar Fors-Nieves; Ummara Shah; Patrick Brown; Carl A Laskin; Nathalie Morel; Kateri Levesque; Jill P Buyon; Earl D Silverman; Peter M Izmirly
Journal:  Ann Rheum Dis       Date:  2018-10-08       Impact factor: 19.103

8.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156

9.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

Review 10.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.